Search
for

    Sort by

    Research 271–300 of 1000+

    1. Effect of Wet Cupping with Rasayana Chikitsa in Management of Alopecia Areata (Indralupt) AYUSHDHARA · 2024 · 1 citations
    2. Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination Annals of Dermatology · 2024 · 1 citations
    3. The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata Annals of Dermatology · 2024 · 1 citations
    4. Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles Clinical, cosmetic and investigational dermatology · 2023 · 1 citations
    5. Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis Acta dermato-venereologica · 2023 · 1 citations
    6. AYURVEDIC MANAGEMENT OF INDRALUPTA (ALOPECIA AREATA) IN CHILDREN: A CASE STUDY International Journal of Research in Ayurveda and Pharmacy · 2023 · 1 citations
    7. Retrospective Analysis of Systemic Corticosteroids for Alopecia Areata in Pediatric Patients Dermatology Archives · 2020 · 1 citations
    8. Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata Quality in Sport · 2026
    9. Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review Frontiers in Immunology · 2026
    10. Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA Dermatology and Therapy · 2026
    11. How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach Dermatology and Therapy · 2026
    12. Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies American Journal of Clinical Dermatology · 2026
    13. Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications Dermatology and Therapy · 2026
    14. Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA Dermatology and Therapy · 2026
    15. Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib Dermatology and Therapy · 2026
    16. A Comparative Study to Evaluate Efficacy of Prachanna Karma Followed by Chirabilva Lepa and Gunja Lepa in the Management of Indralupta w.s.r to Alopecia Areata AYUSHDHARA · 2026
    17. EFFICACY OF INTRALESIONAL BOTULINUM TOXIN INJECTION IN THE TREATMENT OF PATCHY ALOPECIA AREATA (AA) BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · 2026
    18. Retrospective Analysis of Oral Tofacitinib Treatment for Alopecia Areata at a Tertiary Care Hospital in Saudi Arabia Cureus · 2026
    19. Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review 2026
    20. THERAPEUTIC EFFICACY OF RAKTAMOKSHANA AND SHAMANA CHIKITSA IN THE AYURVEDIC MANAGEMENT OF INDRALUPTA (ALOPECIA AREATA): A CASE REPORT International Journal of Research in Ayurveda and Pharmacy · 2025
    21. Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study Cureus · 2025
    22. Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial SKIN The Journal of Cutaneous Medicine · 2025
    23. Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2025
    24. A Systematic Literature Review of Alopecia Areata in Children and Adolescents: Psychosocial Impact SKIN The Journal of Cutaneous Medicine · 2025
    25. Association between air quality index and risk of alopecia areata: A nationwide population-based cohort study  2025
    26. Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata Dermatology and Therapy · 2025
    27. TREATMENT OF ALOPECIA AREATA WITH ORAL METHYLPREDNISOLONE COMBINED WITH FRACTIONAL MICRONEEDLE RADIOFREQUENCY Tạp chí Da liễu học Việt Nam · 2025
    28. Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata Dermatology and Therapy · 2025
    29. Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program SKIN The Journal of Cutaneous Medicine · 2025
    30. Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata 2025